Meeting
2023 ASCO Annual Meeting
Comprehensive profiling of mutational signatures and machine learning and subtypes of homologous recombination deficiency.
Authors
Joonoh Lim
Genome Insight Inc., San Diego, CA
Joonoh Lim , Seongyeol Park , Ryul Kim , Baek-Lok Oh , Sangmoon Lee , Jeong Seok Lee , Ji In Ryu , Jai Min Ryu , Se-Kyung Lee , Byung-Joo Chae , Jeongmin Lee , Ji-Yeon Kim , Yeon Hee Park , Young Seok Ju
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 568)
DOI
10.1200/JCO.2023.41.16_suppl.568
Abstract #
568
Poster Bd #
398
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Detection of homologous recombination deficiency (HRD) in cell-free DNA (cfDNA) using an amplicon-based next-generation sequencing (NGS) assay.
First Author: Jonathan Poh
Poster
2023 ASCO Annual Meeting
A four-tier classification system for studying homologous recombination repair gene reversion mutations as a mechanism of resistance to PARP inhibitors and platinum chemotherapy.
First Author: Qiuxiang Ou
Poster
2023 ASCO Annual Meeting
The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?
First Author: Muhammad Danyal Ahsan
Poster
2022 ASCO Annual Meeting
Comprehensive whole-exome and transcriptome profiling to identify actionable alterations associated with response to PARP inhibitors in breast cancer.
First Author: Susan M. Dombrowski